Catalyst Wire Dossier Catalyst Wire Dossier

Compound Sodium Alginate Double Action Chewable Tablet

sodium alginate · Reckitt Benckiser Healthcare (UK) Limited
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Compound Sodium Alginate Double Action Chewable Tablet, covering 2025-03-13 to 2025-03-13. Get the full timeline:

Most recent: Clinical Trial Update: Compound Sodium Alginate Double Action Chewable Tablet Symptomatic Relief Study [Phase 3]

See pricing